• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Subaortic absorbable ring comprising an open circular segment (1), made of a flexible and resorbable material such as a polydioxanone polymer that when surgically implanted performs annuloplasty. From a first end (2) and from a second end (3) of said open circular segment (1) separate suture threads (4), with respective semicircular needles (5) at their free ends, to bind to the native ring. Once the implantation is completed, the free ends of the suture threads (4) are knotted together, obtaining a closed ring with the desired diameter, which will preferably be 26 millimeters or 28 millimeters, depending on the expansion of the native ring. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2554296A1
    申请号:ES201531420
    申请日:2015-10-02
    公开日:2015-12-17
    发明作者:José Ignacio ARAMENDI GALLARDO
    申请人:José Ignacio ARAMENDI GALLARDO；
    IPC主号:
    专利说明:

    OBJECT OF THE INVENTION
    The present invention falls within the technical field of heart valves, and refers in particular to a reabsorbable subaortic ring to repair aortic valve insufficiencies.
    BACKGROUND OF THE INVENTION
    Severe valvular insufficiency is a disease of the valves that regulate the blood flow in the heart, because of which said valves do not close completely, allowing a return of blood in a direction opposite to the physiological one, which causes an injury Pathological progressive Among all the heart valves, the aortic sigmoid valve, located between the left ventricle and the aortic artery, prevents blood from returning from the aorta to the left ventricle. It consists of three membranes, two anterior and one posterior, and has a morphology similar to that of a swallow's nest. Its insufficiency causes an abnormal blood flow in diastole from the aorta to the left ventricle, which requires repair techniques at various levels, among which are actions on the valve ring.
    Said aortic valve ring has no circular shape, but is similar to a crown with three peaks, coinciding with the areas where the corners are housed. The dilation of this ring, responsible for the improper functioning of the valve, is repaired by an operation known as annuloplasty, consisting of a reduction in the annular diameter until reaching one according to the body size, which in an average adult is about 26 millimeters. This operation allows better coaptation of the veils and helps the repair to be durable and that the native ring, that is, the existing natural ring, does not gradually dilate again.
    Currently, two techniques are known for performing aortic annuloplasty: - Schaffers point, which consists of applying a subaortic circular suture with a Goretex ® point that is implanted internally or externally immediately below the native ring. Unlike this one, it is not necessary to follow the crown shape but it is circular in a strictly horizontal plane. The point is knotted by introducing a Hegar stem, which is a 26 mm cylinder as a mold so that the suture is exactly that diameter. It is an artisanal and imperfect technique, because it lends itself to variability depending on the surgeon and is also rigid and does not allow the changes that occur in the ring depending on the cardiac cycle, since in systole the diameter increases to favor the blood output and in diastole it decreases to its nominal diameter.
    - External coroneo ring, which is a polyethylene terephthalate ring with a very flexible silicone core, which is inserted outside the aorta with 6 fixation points. It allows the diameter changes produced by the cardiac cycle and comes in several sizes from 25 to 29 millimeters. It requires a meticulous dissection of the root of the heart and forces to resect and reimplant the coronary arteries, so it is limited to the most complex cases that require a replacement of the aortic root with preservation of the valve, known as Yacoub operation.
    DESCRIPTION OF THE INVENTION
    The object of the invention consists of a medical device type cardiac prosthesis, and refers to a valve ring, in particular an internal subaortic ring, with an open circle shape to facilitate its implantation in annuloplasty operations, and made of a flexible material and reabsorbable by the human organism, such as a polydioxanone polymer, which eliminates the problems and disadvantages created by the annuloplastic techniques described above.
    Said ring has an open circular shape to facilitate its placement in the patient's valve, said circle being closed at the time of knotting and thus obtaining the appropriate valve diameter, of about 26 millimeters for the case of a standard adult.
    The ring is formed in a tubular structure, preferably with a diameter of 1.5 millimeters made of flexible and resorbable material after approximately one year from the surgical intervention, such as a polydioxanone polymer, which also allows fluctuations common that occur in the native ring in both systole and diastole. Two sizes for the ring are preferably contemplated, specifically 26 and 28 millimeters in diameter.
    This subaortic ring is surgically implanted inside the aortic valve in a horizontal circular manner, as in the Schaffers point technique, burying it in the myocardium just below the native aortic ring. Thus, it is susceptible to being implanted in all cases of aortic repair, without the need to dissect the entire aortic root or to section and reimplant the coronary arteries, unless the aforementioned Yacoub operation is required.
    In more detail, the implantation of this device is done through an "open heart" cardiac intervention to repair aortic valve insufficiency. Once the extracorporeal circulation is connected, the ascending aorta is opened transversely and the aortic valve is exposed. At that time the valve is examined and the veils are analyzed, checking that there is enough tissue and identifying the cause of the insufficiency, which is usually due to the prolapse of a veil. If, depending on the information obtained, the surgeon determines that the valve can be repaired, the native ring is measured by a Hegar stem, verifying that it is effectively dilated, which occurs if its average diameter is greater than 25 millimeters. In the event that said dilation has a measurement between 25 and 28 millimeters, a valve prosthetic ring of 26 millimeters should be implanted, while if said dilation is equal to or greater than 28 millimeters, a 28 millimeter ring will be necessary.
    Once the appropriate ring has been chosen, it is opened and implanted by suturing the extension with monofilament suture thread of one end, starting below the valve plane inside, at the height of the corner between the non-coronary veil and the right coronary, subsequently continue applying points clockwise, progressively burying the prosthetic ring in the myocardium, just below the valve plane.
    Proceed in this way until returning to the aforementioned commissure, at which level the membranous septum is found, which must be avoided encompassing the suture to avoid the occurrence of an atrioventricular block or AV block. To do this, the two needles are passed from the ends of the ring from the inside out of the left ventricle, to the outer space between the ascending aorta and the left atrial roof, leaving the passing needles on both sides of the membranous septum and thus preventing blockage AV.
    Both sutures are knotted outside the heart on a Teflon pad that closes the circle, creating an effective subaortic annuloplasty with the desired size. From this point, the aortic repair would continue according to the usual technique, usually by means of central points in the veil until an adequate height of the veil is achieved. The final quality of the intervention would be checked by transesophageal echocardiographic control.
    The absorbable subaortic ring thus described surgically corrects the dilation of the aortic valve ring, thus avoiding the pathological problems caused by said dilation. Some of its most outstanding advantages are that it is not thrombogenic, that is, it does not constitute a factor that can cause a thrombus or clot, and on the other hand, being buried inside the myocardial ring, in no case comes into contact with the flow blood, thus not requiring anticoagulant or antiplatelet therapy. For the same reason it is resistant to infections, and can be used in cases of endocarditis. Finally, it is totally biocompatible and does not produce rejection.
    DESCRIPTION OF THE DRAWINGS
    To complement the description that is being made and in order to help a better understanding of the characteristics of the invention, according to a preferred example of practical implementation thereof, a set of drawings is attached as an integral part of said description. where, with an illustrative and non-limiting nature, the following has been represented:
    Figure 1. - It shows a plan view of the subaortic ring, prior to its implantation, in which its main constituent elements are appreciated.
    PREFERRED EMBODIMENT OF THE INVENTION
    Next, a detailed explanation of a preferred embodiment of the object of the present invention is provided with the aid of the aforementioned referenced figure.
    The absorbable subaortic ring described comprises an open circular segment
    5 (1), preferably made of a flexible and resorbable material such as a polydioxanone polymer, which when surgically implanted performs the annuloplasty or reduction of a native ring dilated to its natural size. Said open circular segment (1) has an essentially cylindrical and solid structure, preferably with a diameter of 1.5 millimeters.
    From both a first end (2) and a second end (3) of said open circular segment (1) split suture threads (4), preferably materialized in polypropylene monofilaments of 2/0 caliber, to link with the Sick Heart Ring Said suture threads (4) are attached to the first end (2)
    15 And to the second end (3) of the open circular segment without continuity solution and by welding. The free ends of the suture threads (4) comprise semicircular needles (5) to allow the suture threads (4) to be linked to the native tissues by sewing.
    20 The final conformation of the subaortic ring is performed in the last step of its surgical implantation, at which point the semicircular needles (5) are removed from the free ends of the suture threads (4) to knot between them, obtaining a ring closed with the desired diameter, which will preferably be 26 millimeters or 28 millimeters, depending on the dilation of the native ring.
    权利要求:
    Claims (5)
    [1]
    1. Absorbable subaortic ring, specially designed to be implanted in subaortic annuloplasty operations, characterized in that it comprises a segment
    5 open circular (1), from whose first end (2) and second end (3) split twosuture threads (4), whose free ends comprise semicircular needles (5).
    [2]
    2. Absorbable subaortic ring according to claim 1, characterized in that the open circular segment (1) is made of flexible and resorbable material.
    [3]
    3. Absorbable subaortic ring according to claim 2, characterized in that the flexible and resorbable material of the open circular segment (1) comprises a polydioxanone polymer.
    Resorbable subaortic ring according to claim 1, characterized in that the open circular segment (1) comprises a solid cylindrical structure.
    [5]
    5. Absorbable subaortic ring according to claim 1, characterized in that the suture threads (4) comprise polypropylene monofilaments.
    [6]
    6. Absorbable subaortic ring according to claim 4, characterized in that the polypropylene monofilaments of the suture threads (4) are of a 2/0 caliber.
    类似技术:
    公开号 | 公开日 | 专利标题
    JP6721770B2|2020-07-15|Structural member for artificial mitral valve
    ES2236204T3|2005-07-16|BULBIFORM AND STENT VALVE FOR THE TREATMENT OF VASCULAR REFLUX.
    ES2204971T3|2004-05-01|REPLACEMENT OF HEART VALVES USING FLEXIBLE TUBES.
    CN107530159A|2018-01-02|Devices, systems, and methods for cardiac treatment
    ES2310598T3|2009-01-16|MANUFACTURING PROCEDURE OF A VALVULAR PROTESIS FOR THE HEART.
    ES2202369T3|2004-04-01|APPARATUS TO REDUCE THE CIRCUMFERENCE OF VASCULAR STRUCTURE.
    ES2253325T3|2006-06-01|ENDOVASCULAR PROTESIS WITH VALVE.
    JP5877205B2|2016-03-02|Intra-annular mounting frame for aortic valve repair
    ES2554296B1|2017-01-18|REABSORBABLE SUBAORTIC RING
    US20210196446A1|2021-07-01|Vascular prosthesis for use in the treatment of arterial diseases
    US20090177271A1|2009-07-09|Prosthesis for Ascending Aortic Segment and Method for Surgical Treatment of an Aortic Valve Leak
    JP2009500088A|2009-01-08|Valved patch and valved tube used to repair the outflow tract of the heart
    RU2474403C1|2013-02-10|Valve-containing aortic root prosthesis
    US20190321168A1|2019-10-24|Naturally designed mitral prosthesis
    RU2649139C1|2018-03-29|Method of fixation of puppilary intraocular lenses after its implantation on eyes without capsul support
    RU2676660C1|2019-01-09|Method of treating infectious endocarditis, biological valve containing conduit of ascending aorta for its implementation and method for conduit manufacture
    RU2624313C1|2017-07-03|Method of implantation of prosthesis of heart valve into aortal position in mitral-aortal prosthetics
    RU2723355C1|2020-06-10|Method for making cardiovascular prosthesis of pulmonary artery with three-leaf valve and cardiovascular prosthesis made by method thereof
    US20220047387A1|2022-02-17|Naturally designed mitral prosthesis
    RU2696057C2|2019-07-30|Method of performing norwood operation, vascular homograft and method for producing vascular homograft
    RU192707U1|2019-09-26|Transcatheter mitral valve prosthesis
    RU2716062C1|2020-03-05|Method of making a bifurcated conduit of the pulmonary artery and a bifurcating conduit made by this method
    RU2466695C1|2012-11-20|Valve-containing pulmonary arterial graft
    CN212788787U|2021-03-26|Artificial heart valve
    JP7015866B2|2022-02-03|Structural members for artificial mitral valves
    同族专利:
    公开号 | 公开日
    ES2554296B1|2017-01-18|
    ES2670715T3|2018-05-31|
    EP3150173A1|2017-04-05|
    EP3150173B1|2018-02-28|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2001089426A1|2000-05-25|2001-11-29|Bioring S.A.|Device for shrinking or reinforcing the heart valvular orifices|
    US6506197B1|2000-11-15|2003-01-14|Ethicon, Inc.|Surgical method for affixing a valve to a heart using a looped suture combination|
    US20030191479A1|2002-04-03|2003-10-09|Thornton Sally C.|Body lumen closure|
    FR2858543A1|2003-08-08|2005-02-11|Assist Publ Hopitaux De Paris|Artificial aortic ring of supple biocompatible material is designed to be implanted round root of aorta beneath valves and coronary arteries|
    US20120136435A1|2010-11-30|2012-05-31|Edwards Lifesciences Corporation|Reduced Dehiscence Annuloplasty Ring|
    IT1218951B|1988-01-12|1990-04-24|Mario Morea|PROSTHETIC DEVICE FOR SURGICAL CORRECTION OF TRICUSPIDAL INSUFFICENCE|
    US6416549B1|1999-07-19|2002-07-09|Sulzer Carbomedics Inc.|Antithrombogenic annuloplasty ring having a biodegradable insert|
    US8206439B2|2004-02-23|2012-06-26|International Heart Institute Of Montana Foundation|Internal prosthesis for reconstruction of cardiac geometry|
    RU2580479C2|2010-11-09|2016-04-10|ЭТИКОН ЭлЭлСи|Emergency self-retaining sutures and packaging therefor|US9345573B2|2012-05-30|2016-05-24|Neovasc Tiara Inc.|Methods and apparatus for loading a prosthesis onto a delivery system|
    CN111263622A|2017-08-25|2020-06-09|内奥瓦斯克迪亚拉公司|Sequentially deployed transcatheter mitral valve prosthesis|
    法律状态:
    2017-01-18| FG2A| Definitive protection|Ref document number: 2554296 Country of ref document: ES Kind code of ref document: B1 Effective date: 20170118 |
    2021-10-04| FD2A| Announcement of lapse in spain|Effective date: 20211004 |
    优先权:
    申请号 | 申请日 | 专利标题
    ES201531420A|ES2554296B1|2015-10-02|2015-10-02|REABSORBABLE SUBAORTIC RING|ES201531420A| ES2554296B1|2015-10-02|2015-10-02|REABSORBABLE SUBAORTIC RING|
    ES16382452.7T| ES2670715T3|2015-10-02|2016-10-03|Absorbable subaortic ring|
    EP16382452.7A| EP3150173B1|2015-10-02|2016-10-03|Reabsorbable subaortic ring|
    [返回顶部]